What does MEDICA DERMIS do?

MEDICA DERMIS is a specialist medical practice in Waterloo. Private Limited, started on 8 August 2013, 1 establishment.

What is the address of MEDICA DERMIS?

The registered office of MEDICA DERMIS is located at Drève de la Vannette 10, 1410 Waterloo.

Is MEDICA DERMIS still active?

Yes. According to the CBE (29 September 2026) MEDICA DERMIS is active, legal situation “Normale toestand”, started on 8 August 2013.

Is MEDICA DERMIS registered on Peppol?

Yes, MEDICA DERMIS is registered on the Peppol network with ID 0208:0537597556.

What is the enterprise number of MEDICA DERMIS?

The enterprise number of MEDICA DERMIS is BE0537597556.

When was MEDICA DERMIS founded?

MEDICA DERMIS was founded on 8 August 2013.

Who are the directors of MEDICA DERMIS?

According to the 2025 annual accounts, the directors of MEDICA DERMIS are: Laetitia GOUDETSIDIS.

Is MEDICA DERMIS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 August 2013; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDICA DERMIS make in 2025?

MEDICA DERMIS posted a profit after taxes of € 5,674 in financial year 2025.

What is the revenue of MEDICA DERMIS?

As a small company, MEDICA DERMIS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 30,495.

MEDICA DERMIS (Private Limited) - Waterloo - BE0537597556

Dossier MEDICA DERMIS, printed on 29 September 2026 from databakkes.be/en/0537597556/medica-dermis. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MEDICA DERMIS from Waterloo, company number BE0537597556, closed financial year 2025 with a result of € 5,674 after tax. For that financial year MEDICA DERMIS recorded a gross margin of € 30,495 and equity of € 68,127. Compared with financial year 2024, the result moved from € -24,230 to € 5,674. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on February 1, 2026.

What it is worth Growing

€ 68,127

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 5,674

▲ still € 24,230 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 10,549

▲ 76% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 55,727.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 8,308

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 15 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 243,608

▼ 7% vs 2024

€ 15,756 is repaid this year. At this pace the long-term loan is gone in ≈ 15 years.

Owed to suppliers

€ 262

▼ 72% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,600

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 66,894 Gross margin 2022: € 66,894 First fiscal year in the series	€ 22,117 Gross margin 2023: € 22,117 ▼ 67% vs 2022 (€ 66,894) Unfavourable step	€ 9,996 Gross margin 2024: € 9,996 ▼ 55% vs 2023 (€ 22,117) Unfavourable step	€ 30,495 Gross margin 2025: € 30,495 ▲ 205% vs 2024 (€ 9,996) Favourable step	▲ 205%
Profit after taxes	€ 10,259 Profit after taxes 2022: € 10,259 First fiscal year in the series	€ -22,464 Profit after taxes 2023: € -22,464 ▼ € 32,722 vs 2022 (€ 10,259) Unfavourable step	€ -24,230 Profit after taxes 2024: € -24,230 ▼ € 1,767 vs 2023 (€ -22,464) Unfavourable step	€ 5,674 Profit after taxes 2025: € 5,674 ▲ € 29,904 vs 2024 (€ -24,230) Favourable step	▲ € 29,904
Equity	€ 109,147 Equity 2022: € 109,147 First fiscal year in the series	€ 86,683 Equity 2023: € 86,683 ▼ 21% vs 2022 (€ 109,147) Unfavourable step	€ 62,453 Equity 2024: € 62,453 ▼ 28% vs 2023 (€ 86,683) Unfavourable step	€ 68,127 Equity 2025: € 68,127 ▲ 9% vs 2024 (€ 62,453) Favourable step	▲ 9%
Total debts	€ 297,765 Total debts 2022: € 297,765 First fiscal year in the series	€ 290,078 Total debts 2023: € 290,078 ▼ 3% vs 2022 (€ 297,765) Favourable step	€ 273,573 Total debts 2024: € 273,573 ▼ 6% vs 2023 (€ 290,078) Favourable step	€ 255,310 Total debts 2025: € 255,310 ▼ 7% vs 2024 (€ 273,573) Favourable step	▼ 7%
Cash	€ 57,630 Cash 2022: € 57,630 First fiscal year in the series	€ 24,730 Cash 2023: € 24,730 ▼ 57% vs 2022 (€ 57,630) Unfavourable step	€ 5,979 Cash 2024: € 5,979 ▼ 76% vs 2023 (€ 24,730) Unfavourable step	€ 10,549 Cash 2025: € 10,549 ▲ 76% vs 2024 (€ 5,979) Favourable step	▲ 76%
Land & buildings	€ 317,933 Land & buildings 2022: € 317,933 First fiscal year in the series	€ 318,370 Land & buildings 2023: € 318,370 Unchanged (€ 317,933) Unchanged	€ 308,496 Land & buildings 2024: € 308,496 ▼ 3% vs 2023 (€ 318,370) Unchanged	€ 297,965 Land & buildings 2025: € 297,965 ▼ 3% vs 2024 (€ 308,496) Unchanged	▼ 3%
Retained profit	€ 96,747 Retained profit 2022: € 96,747 First fiscal year in the series	€ 74,283 Retained profit 2023: € 74,283 ▼ 23% vs 2022 (€ 96,747) Unfavourable step	€ 50,053 Retained profit 2024: € 50,053 ▼ 33% vs 2023 (€ 74,283) Unfavourable step	€ 55,727 Retained profit 2025: € 55,727 ▲ 11% vs 2024 (€ 50,053) Favourable step	▲ 11%
Bank debt	€ 295,996 Bank debt 2022: € 295,996 First fiscal year in the series	€ 278,615 Bank debt 2023: € 278,615 ▼ 6% vs 2022 (€ 295,996) Favourable step	€ 262,005 Bank debt 2024: € 262,005 ▼ 6% vs 2023 (€ 278,615) Favourable step	€ 243,608 Bank debt 2025: € 243,608 ▼ 7% vs 2024 (€ 262,005) Favourable step	▼ 7%
Balance sheet total	€ 406,912 Balance sheet total 2022: € 406,912 First fiscal year in the series	€ 376,762 Balance sheet total 2023: € 376,762 ▼ 7% vs 2022 (€ 406,912) Unchanged	€ 336,026 Balance sheet total 2024: € 336,026 ▼ 11% vs 2023 (€ 376,762) Unchanged	€ 323,437 Balance sheet total 2025: € 323,437 ▼ 4% vs 2024 (€ 336,026) Unchanged	▼ 4%

Key figures of MEDICA DERMIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to MEDICA DERMIS?

What happened at MEDICA DERMIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 1, 2026 New annual accounts for financial year 2025: profit of € 5,674. filed late Source: NBB ↗
2023 Laetitia GOUDETSIDIS became a director. NBB
Aug 21, 2013 New establishment in Waterloo. KBO
Aug 8, 2013 Start of the company according to the CBE. KBO

In short

From € 10,259 profit in 2022 to € 5,674 profit in 2025.

Paid € 30,544 in corporate taxes since 2022.

Best year ever: 2022, with € 10,259 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MEDICA DERMIS? We notify you, reason included.

Follow MEDICA DERMIS

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Laetitia GOUDETSIDIS

MEDICA DERMIS

Behind MEDICA DERMIS is Laetitia GOUDETSIDIS.

See the full network in the app

Directors

According to the 2025 annual accounts

Laetitia GOUDETSIDIS

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Drève de la Vannette 10

1410 Waterloo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0537.597.556
VAT number: BE 0537.597.556
Registered office: Drève de la Vannette 10, 1410 Waterloo
Names & denominations: MEDICA DERMIS
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 August 2013
Peppol: Active · Active since 9 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗